New vaccine for virus that causes respiratory disease approved for Singaporeans over 60

The vaccine, called Arexvy, protects against the respiratory syncytial virus, and was developed by British pharmaceutical giant GSK. - The Straits Times

SINGAPORE: Singaporeans aged 60 and above can now get vaccinated against a contagious virus that causes respiratory tract infections and could lead to complications in older folk.

The vaccine, called Arexvy, protects against the respiratory syncytial virus (RSV), and was developed by British pharmaceutical giant GSK.